Evidence Central | Infliximab in Crohn's disease

Download the app!

INSTALL

Infliximab in Crohn's disease

52 results

1 - 52

Infliximab in Crohn's disease
- Evidence Summaries
- References
Infliximab in chronic active Crohn's disease
- Evidence Summaries
- References
Azathioprine or 6‐mercaptopurine for induction of remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Methotrexate for induction of remission in refractory Crohn's disease: Cochrane systematic review
- Abstract
- Summary
- Reviewer's Conclusions
Tumor necrosis factor‐alpha antibody for maintenance of remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Tumor necrosis factor-alpha antibody for maintenace of remission in Crohn's disease
- Evidence Summaries
Infliximab effect for ulcerative colitis
- Bottom Line
- Synopsis
Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease
- Evidence Summaries
Crohn’s disease
- Arrangement of treatment
Natalizumab for induction of remission in Crohn's disease
- Abstract
Tumor necrosis factor‐alpha antibody for induction of remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Azathioprine or 6‐mercaptopurine for maintenance of remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Methotrexate for maintenance of remission in Crohn's disease: Cochrane systematic review
- Abstract
- Summary
- Reviewer's Conclusions
Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease
- Abstract
- Reviewer's Conclusions
Interventions for prevention of post‐operative recurrence of Crohn's disease
- Abstract
- Reviewer's Conclusions
Enteral nutrition for maintenance of remission in Crohn's disease
- Reviewer's Conclusions
Methotrexate for maintenance of remission in Crohn's disease
- Evidence Summaries
Azathioprine or 6-mercaptopurine for maintaining remission in Crohn's disease
- Evidence Summaries
Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis
- Abstract
- Reviewer's Conclusions
Anti‐IL‐12/23p40 antibodies for maintenance of remission in Crohn's disease
- Abstract
Interventions for maintenance of surgically induced remission in Crohn’s disease: a network meta‐analysis
- Abstract
Interventions for prevention of post-operative recurrence of Crohn's disease
- Evidence Summaries
Interventions for growth failure in childhood Crohn's disease
- Abstract
Adalimumab for maintenance of remission in Crohn's disease
- Abstract
Helminth therapy (worms) for induction of remission in inflammatory bowel disease: Cochrane systematic review
- Summary
Antibiotics for induction and maintenance of remission in Crohn's disease
- Abstract
Use of medication during pregnancy
- Essentials
** Update Information **
- Latest Update
1 - 52 of 52 records

Log in to Evidence Central

Contact Support

If you need further assistance, please contact Support.

unboundmedicine.com/support
support@unboundmedicine.com
610-627-9090(Monday - Friday, 9 AM - 5 PM EST.)

Password reset sent

Username sent

A Evidence Central subscription is required to

Already have an account?